Recruiting

CCHS Registry

Sponsor:

Ilya Khaytin

Code:

NCT03088020

Conditions

Congenital Central Hypoventilation Syndrome

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The Center for Autonomic Medicine in Pediatrics (CAMP), in collaboration with leading CCHS clinicians, scientists, and patient advocacy groups around the world has built the first International CCHS (Congenital Central Hypoventilation Syndrome REDCap (Research Electronic Data Capture) Registry. This registry is an international collaboration to capture CCHS natural history data with CCHS patients and their physicians recruited from around the world. This registry is part of a CCHS natural history study that includes the CCHS Secure Health-hub Advancing Research Efforts (CCHS-SHARE), a natural history data platform shared with the broader CCHS research and patient community to house extensive longitudinal, de-identified data. Inclusion of registry data in CCHS-SHARE is optional.

The purpose of this IRB-approved research study is to gain a better understanding of the natural history of CCHS, including the various clinical manifestations of CCHS with advancing age, and as related to each patient's specific PHOX2B mutation. With a better understanding of CCHS natural history, we will be able to better anticipate healthcare needs and to provide more accurate guidelines to healthcare providers world-wide in caring for patients with CCHS.

The study aims to obtain detailed phenotypic information (information about health and well-being) on patients with CCHS and their families. Participation would require filling out a confidential survey that asks questions regarding phenotype and past medical history. Involvement in the project is completely voluntary and there is no compensation for taking part. However, this project will help us learn more about this disease, with the goal of advancing treatment.

Conditions

Congenital Central Hypoventilation Syndrome

Study ID

NCT03088020

Start date

Jun 24, 2013

Status verified date

Aug, 2026

Completion date

Dec 31, 2032

Anticipated

Primary completion date

Dec 31, 2031

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Individuals with PHOX2B mutation-confirmed CCHS.

Exclusion Criteria:

  • Individuals without PHOX2B mutation-confirmed CCHS.

Study Design

Enrollment

1000 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Longitudinal phenotype in CCHS [ Time Frame: 20 years ]

Central Contacts and Locations

Central contacts

Locations

Ann & Robert H. Lurie Children's Hospital of Chicago and the Stanley Manne Children's Research Institute

Recruiting

Chicago, Illinois, United States, 60611

Contacts

More Information

Sponsor

Ilya Khaytin

Last update posted

Sep 3, 2026

Last verified

Aug, 2026

Keywords

  • CCHS
  • PHOX2B
  • Paired-like Homeobox gene PHOX2B
  • autonomic nervous system dysregulation
  • control of breathing
  • Hirschsprung disease
  • neural crest tumors
  • neuroblastoma
  • ganglioneuroma
  • ganglioneuroblastoma
  • artificial ventilation
  • diaphragm pacing

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Ilya Khaytin on 2026-09-03.